Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18362366 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: A (Thalidomide + Dexamethasone);   Drug: B (Placebo + Dexamethasone)

Indicates status has not been verified in more than two years